Clinical Trial Update: Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor [Phase 3]

View source ↗

Summary

Phase III study comparing ATG-thymoglobulin vs ATLG-grafalon for GVHD prophylaxis in elderly AML/MDS patients undergoing matched unrelated donor allogeneic stem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Graft-versus-host Disease
• Myelodysplastic Syndrome

Drugs mentioned

• ATG-thymoglobulin (thymoglobulin)
• ATLG (Grafalon) (Grafalon)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: GVHD | Phase 3 | Status: RECRUITING